Actos-Bladder Cancer cases are becoming prevalent, New York Attorney reports

1
Actos-Bladder Cancer cases are becoming
prevalent, New York Attorney reports
(1888PressRelease) Actos related Bladder Cancer
cases are becoming prevalent according to Rudolph
F.X. Migliore, P.C. The firm has been accepting
the cases since July 2011 and has seen a number
of inquiries into the litigation. The diabetes
drug Actos may be linked to Bladder Cancer. While
the FDA's highest warning appears on Actos for
its heart attack risk, no such warning appears
for Bladder Cancer. Research has shown that
taking Actos for more than 1 year may increase a
patient's chance for developing Bladder Cancer by
up to 40. With over 2 million people prescribed
Actos, the law firm of Rudolph F.X. Migliore,
P.C. has seen a number of inquiries related to
Actos litigation. Actos is used to regulate the
level of glucose in the bloodstream in patients
with type 2 diabetes. Diabetes is a prevalent
disease in the United States and Actos use has
steadily increased, especially after a similar
prescription drug, Avandia, was pulled off the
market because it was linked to an increased risk
for heart attacks. The relationship of Actos to
bladder cancer has only recently been examined
and consequences are being monitored by the FDA.
In August 2011, the FDA approved updated labeling
for Actos stating that taking the drug "for more
than one year may be associated with an increased
risk of bladder cancer". The FDA has been
conducting an ongoing review of the connection
between Actos (pioglitazone) and Bladder Cancer
based on studies conducted over the last 10 years
by the drugs' manufacturers, as well as studies
done in Europe which suggested an increased risk
from using Actos (pioglitazone) and developing
Bladder Cancer.
2
As this potential link has become more prevalent,
the law firm of Rudolph F.X. Migliore, P.C. has
been hearing from patients that have been taking
Actos for an extended period of time and have
developed bladder cancer. The firm initially
started investigating case related to Actos and
Bladder Cancer from throughout the United States
in July 2011 and is continuing to accept
cases. With over three decades of experience,
the law firm of Rudolph F.X. Migliore, P.C. is
well positioned to help victims of Actos related
Bladder Cancer. The firm works with nationally
recognized co-council to provide powerful
representation for their clients, while providing
them with personalized service. If you or a loved
one has been harmed while taking Actos, call
Rudolph F.X. Migliore, P.C. at 631-543-3663 or
visit Migliorelaw.com . Source http//www.1888pr
essrelease.com/actos-bladder-cancer-cases-are-beco
ming-prevalent-new-york-pr-332651.html